References
- KluwerWoltersStandard Population Data2008 Available at: http://www.wolterskluwer.comAccessed November 8, 2011
- North American Menopause SocietyThe role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of the North American Menopausal SocietyMenopause2007143 Pt 135536917438512
- ShulmanLPPortmanDJLeeWCA retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practiceJ Womens Health (Larchmt)200817456957818429700
- NilssonKHeimerGLow-dose oestradiol in the treatment of urogenital oestrogen deficiency-a pharmacokinectic and pharmacodynamics studyMaturitas19921521211271470044
- MaininiGScaffaCRotondiMMessalliEMQuirinoLRagucciALocal estrogen replacement therapy in postmenopausal atrophic vaginitis: efficacy and safety of low-dose 17b-estradiol vaginal tabletsClin Exp Obstet Gynecol200532211111316108394
- RiouxJEDevlinCGelfandMMSteinburgWMHepburnDS17b-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitisMenopause20007315616110810960
- DugalRHeslaKSørdalTAaseKHLilleeidetOWickstrømEComparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophyActa Obstet Gynecol Scand200079292297
- SimunićVBanovićICiglarSJerenLPavicić BaldaniDSpremMLocal estrogen treatment in patients with urogenital symptomsInt J Gynaecol Obstet200382218719712873780
- NotelovitzMFunkSNanavatiNMazzeoNEstradiol absorption from vaginal tablets in postmenopausal womenObstet Gynecol200299455656212039110
- BachmannGRogerioAGutRNachtigallLNotelovitzMEfficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trialObstet Gynecol20081111677618165394
- SimonJNachtigallLGutRLangEArcherDUtianWEffective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tabletObstet Gynecol200811251053106018978105
- UlrichLSNaessenTEliaDGoldsteinJAEugster-HausmannMVAG-1748 trial investigatorsEndometrial safety of ultra-low-dose Vagifen 10 mcg in postmenopausal women with vaginal atrophyClimacteric201013322823720423243
- SimonJNachtigallLUlrichLGEugster-HausmannMGutREndometrial safety of ultra-low-dose estradiol vaginal tabletsObstet Gynecol2010116487688320859151
- NotelovitzMFunkSNanavatiNMazzeoNEstradiol absorption from vaginal tablets in postmenopausal womenObstet Gynecol200299455656212039110
- Eugster-HausmannMWaitzingerJLehnickDMinimized estradiol absorption with ultra-low-dose 10 microg 17beta-estradiol vaginal tabletsClimacteric201013321922720423242
- Mayo Clinic A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic VaginitisClinicalTrialsgov [Internet]Bethesda, MDNational Library of Medicine (US)2008 Available from: http://clinicaltrials.gov/ct2/show/NCT00816556.NLMIdentifier:NCT00816556
- NordiskNovoVagifem 10 mcg to replace Vagifem 25 mcg formulation for atrophic vaginitis due to menopause Available at: http://press.novonordisk-us.com/index.php?s=43&item=252Accessed October 7, 2010